A carregar...
Reversal Agents in the Era of NOACs
The incidence and prevalence of atrial fibrillation (AF) is expected to more than double between 2010 and 2030. Accordingly, the use of non-vitamin K oral anticoagulant (NOAC) agents for thromboembolic stroke prevention is anticipated to increase. The development of effective and safe antidotes is n...
Na minha lista:
| Publicado no: | J Atr Fibrillation |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cardiofront, Inc
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5821629/ https://ncbi.nlm.nih.gov/pubmed/29487678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.1634 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|